Azilsartan kamedoxomil is an organic potassium salt that is the monopotassium salt of azilsartan medoxomil. A prodrug for azilsartan, it is used for treatment of hypertension. Among its listed roles, it functions as a prodrug, an antihypertensive agent and an angiotensin receptor antagonist. It includes a azilsartan medoxomil(1-). AZILSARTAN KAMEDOXOMIL is a small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2011 and is indicated in hypertension and stroke. This drug has a black box warning from the FDA. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Azilsartan medoxomil potassium, Edarbi (TN) and Azilsartan Medoxomil Monopotassium Salt. Its PubChem CID is 23699544.
Azilsartan kamedoxomil
| CAS No | 863031-24-7 |
|---|---|
| Molecular Formula | C30H23KN4O8 |
| Molecular Weight | 606.6 g/mol |
| Synonyms | potassium;(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-3-[[4-[2-(5-oxo-1-oxa-2-aza-4-azanidacyclopent-2-en-3-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Azilsartan kamedoxomil is an organic potassium salt that is the monopotassium salt of azilsartan medoxomil. A prodrug for azilsartan, it is used for treatment of hypertension.
The listed CAS number is 863031-24-7.
The listed molecular formula is C30H23KN4O8.
The listed molecular weight is 606.6 g/mol.
potassium;(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-3-[[4-[2-(5-oxo-1-oxa-2-aza-4-azanidacyclopent-2-en-3-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate.
The source lists Azilsartan medoxomil potassium, Edarbi (TN) and Azilsartan Medoxomil Monopotassium Salt.